A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

计划入组 61 人 · 首次发布于 2018 年 7 月 11 日

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

计划入组 15 人 · 首次发布于 2018 年 3 月 12 日

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

计划入组 30 人 · 首次发布于 2015 年 9 月 30 日

Ebola Zaire vaccine (live, attenuated)(Zabdeno)

Ansuvimab(Ebanga)

Ebolavirus vaccine(Uvaxbio)

Med-caire, Inc.

United States

Mountain Aire Medical Supply, Inc.

United States

SK Bioscience Partners with MSD and Hilleman Labs on $30M CEPI-Funded Zaire Ebola Vaccine Development

WHO Recommends Regeneron's Maftivimab for Clinical Trials Against Bundibugyo Ebolavirus Outbreak

Ugandan Biotech Company Files US Patent for Multi-Strain Ebola mRNA Vaccine Platform